REMUS PHARMACEUTICALS L Share Price

REMUS PHARMACEUTICALS L Share Price

NSE: REMUS
|
Trading
|
S Cap
₹ 986.00
+₹34.85 (3.66%)
1D
Last updated 23 Sep, 2026, 14:24 IST

REMUS PHARMACEUTICALS L Share Price Today

As of 23 Sep 2026, REMUS PHARMACEUTICALS L share price is ₹986.00. The stock opened at ₹955.00, compared to its previous close of ₹951.15. During today's trading session, REMUS PHARMACEUTICALS L share price moved in the range of ₹955.00 to ₹989.90, with an average price of ₹972.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹580.00 and a high of ₹1,007.00. On the performance front, REMUS PHARMACEUTICALS L share price has increased by 46.26% over the last six months and is up 19.12% on a year-on-year basis.

₹955.00
3.66% up today
₹989.90
1D LOW
1D HIGH

REMUS PHARMACEUTICALS L Returns Calculator

Circuit
L
H
₹760.95
₹1,141.35
52-week
L
H
₹580.00
₹1,007.00

About REMUS PHARMACEUTICALS L

REMUS PHARMACEUTICALS L Share Price
ISIN
INE0O5T01011
Sector Market Cap
₹ 1,165.20 Cr

Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.

REMUS PHARMACEUTICALS L Financial Highlights

  • Revenue: REMUS PHARMACEUTICALS L reported revenue of ₹860.33 crore in FY26 vs ₹625.34 crore in FY25. It showed an increase of 37.58% on a yearly basis.
  • Operating Profit: REMUS PHARMACEUTICALS L reported an operating profit of ₹59.16 crore in FY26 vs ₹47.34 crore in FY25. It showed an increase of 24.97% on a year-on-year basis.
  • Net Profit: REMUS PHARMACEUTICALS L reported a net profit of ₹46.17 crore in FY26 vs ₹38.42 crore in FY25. It showed an increase of 20.17% on a yearly basis.
Know more
Promoters
70.95%
FII
5.28%
Other DII
0.83%
Retail and other
22.93%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20254.77%
Jul 20255.03%
Sep 20255.02%
Mar 20265.28%
Mkt Cap Cr
1,319.19
P/E
45.36
P/B
3.44
ROE
7.59%
D/E
0.02
ROCE
10.19%
Div. Yield
0.05%
EPS(TTM)
20.96
Turnover
0.26
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
5.00
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Remus Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Remus Pharma. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Remus Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

REMUS PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Revenue₹620.36₹212.50
Other Income₹4.98₹5.40
Total Revenue₹625.34₹217.90
Total Expenses₹578.00₹186.07
Profit Before Tax₹47.34₹31.83
Tax₹8.92₹5.85
Profit After Tax₹38.42₹25.98
EPS - Basic₹65.21₹152.01
EPS - Diluted₹65.21₹152.01

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Profit before tax₹47.34₹31.83
Income before WC changes₹47.57₹31.05
Change in Assets-₹3.37-₹57.10
Change in Liabilities-₹29.74₹36.22
Change in WC-₹33.11-₹20.88
Cash flow from Operations₹6.99₹3.60
Cash flow from Investing-₹10.55-₹8.94
Cash flow from Financing₹6.07₹24.37
Total Cash Flow₹2.51₹19.03
Cash (Start of the year)₹4.72₹7.84
Cash (End of the year)₹7.23₹26.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024
Non-Current Assets₹211.27₹47.53
Current Assets₹221.37₹209.74
Total Assets₹432.64₹257.27
Current Liabilities₹121.53₹149.48
Net Current Asset₹99.84₹60.26
Non-Current Liabilities₹28.56₹3.46
Equity Capital₹282.55₹104.33
Total Equity & Liabilities₹432.64₹257.27

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹79.16₹63.94₹45.03₹24.72
Other Income₹2.91₹2.81₹1.58₹0.72
Total Revenue₹82.07₹66.75₹46.60₹25.44
Total Expenses₹55.43₹44.40₹35.19₹20.82
Profit Before Tax₹26.64₹22.35₹11.41₹4.61
Tax₹6.74₹5.73₹2.91₹1.18
Profit After Tax₹19.90₹16.62₹8.50₹3.43
EPS - Basic₹33.75₹29.40₹83.24₹34.34
EPS - Diluted₹33.75₹29.40₹83.24₹34.34

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹26.64₹22.35₹11.41₹4.61
Income before WC changes₹26.69₹21.59₹11.58₹4.61
Change in Assets-₹0.58-₹15.83-₹1.77₹0.12
Change in Liabilities-₹3.00₹6.80-₹1.51₹1.50
Change in WC-₹3.58-₹9.03-₹3.27₹1.62
Cash flow from Operations₹15.59₹6.31₹5.31₹5.04
Cash flow from Investing-₹12.42-₹47.24-₹15.19-₹4.55
Cash flow from Financing-₹1.42₹41.63₹11.77-₹0.17
Total Cash Flow₹1.75₹0.70₹1.89₹0.32
Cash (Start of the year)₹1.71₹1.01₹1.15₹0.83
Cash (End of the year)₹3.46₹1.71₹3.04₹1.15

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹226.40₹134.61₹23.32₹8.17
Current Assets₹53.91₹48.88₹11.34₹7.69
Total Assets₹280.31₹183.49₹34.66₹15.86
Current Liabilities₹11.08₹14.92₹8.16₹9.18
Net Current Asset₹42.83₹33.96₹3.18-₹1.49
Non-Current Liabilities₹27.01₹15.02₹7.36₹0.10
Equity Capital₹242.22₹153.55₹19.14₹6.58
Total Equity & Liabilities₹280.31₹183.49₹34.66₹15.86
* All values are in INR Crore
Qty
Bid
100
980.1
100
980.05
100
964.05
100
964
500
961.1
Ask
Qty
986
200
987.95
100
988
100
988.8
100
990
100
Bid Total: 900
Ask Total: 600
Buy orders: 60%
Sell orders: 40%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.18
Neutral
ATR (14)
43.82
Neutral
STOCH(9,6)
67.51
Neutral
STOCH RSI (14)
57.69
Neutral
ADX(9)
21.4
Bearish
UO(9)
58.27
Neutral
ROC(12)
6.38
Bullish
WillR(14)
-32.49
Neutral
Period
Simple value
Exponential vaue
5D
951.49
952.28
10D
925.69
934.45
20D
910.89
913.49
50D
843.54
863.44
100D
799.23
812.15
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
REMUS PHARMACEUTICALS L Share Price
REMUS PHARMACEUTICALS L
Trading
Add Stock
Add Another

REMUS PHARMACEUTICALS L Share Price FAQs

REMUS PHARMACEUTICALS L share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837